Edmiston KH - Search Results

1

Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells.

Jessup JM, Laguinge L, Lin S, Samara R, Aufman K, Battle P, Frantz M, Edmiston KH, Thomas P. Jessup JM, et al. Among authors: edmiston kh. Int J Cancer. 2004 Sep 1;111(3):332-7. doi: 10.1002/ijc.20264. Int J Cancer. 2004. PMID: 15221959

2

Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells.

Jessup JM, Battle P, Waller H, Edmiston KH, Stolz DB, Watkins SC, Locker J, Skena K. Jessup JM, et al. Among authors: edmiston kh. Cancer Res. 1999 Apr 15;59(8):1825-9. Cancer Res. 1999. PMID: 10213485

3

In vivo induction of murine cytokine production by carcinoembryonic antigen.

Edmiston KH, Gangopadhyay A, Shoji Y, Nachman AP, Thomas P, Jessup JM. Edmiston KH, et al. Cancer Res. 1997 Oct 1;57(19):4432-6. Cancer Res. 1997. PMID: 9331108

4

Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells.

Edmiston KH, Shoji Y, Mizoi T, Ford R, Nachman A, Jessup JM. Edmiston KH, et al. Cancer Res. 1998 Apr 1;58(7):1524-31. Cancer Res. 1998. PMID: 9537259

5

Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells.

Jessup JM, Ishii S, Mitzoi T, Edmiston KH, Shoji Y. Jessup JM, et al. Among authors: edmiston kh. Clin Exp Metastasis. 1999;17(6):481-8. doi: 10.1023/a:1006685817395. Clin Exp Metastasis. 1999. PMID: 10763913

6

Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.

Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston KH, Liotta LA, Petricoin EF 3rd. Speer R, et al. Among authors: edmiston kh. Cancer Genomics Proteomics. 2007 May-Jun;4(3):157-64. Cancer Genomics Proteomics. 2007. PMID: 17878519 Free article. Review.

7

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.

Wulfkuhle JD, Edmiston KH, Liotta LA, Petricoin EF 3rd. Wulfkuhle JD, et al. Among authors: edmiston kh. Nat Clin Pract Oncol. 2006 May;3(5):256-68. doi: 10.1038/ncponc0485. Nat Clin Pract Oncol. 2006. PMID: 16683004 Review.

8

Molecular network analysis using reverse phase protein microarrays for patient tailored therapy.

Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston KH, Liotta LA, Petricoin EF 3rd. Speer R, et al. Among authors: edmiston kh. Adv Exp Med Biol. 2008;610:177-86. doi: 10.1007/978-0-387-73898-7_13. Adv Exp Med Biol. 2008. PMID: 18593023 Review. No abstract available.

9

Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.

Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA. Espina V, et al. Proteomics Clin Appl. 2009 Aug 1;3(8):874-882. doi: 10.1002/prca.200800001. Proteomics Clin Appl. 2009. PMID: 20871745 Free PMC article.

10

A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.

Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: edmiston kh. Mol Cell Proteomics. 2008 Oct;7(10):1998-2018. doi: 10.1074/mcp.M700596-MCP200. Epub 2008 Jul 30. Mol Cell Proteomics. 2008. PMID: 18667411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters